A Translational Roadmap for Neurological Nonsense Mutation Disorders
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27031418 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Jiaqing Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Codon, Nonsense, Nervous System Diseases. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology.
Abstract (Originalsprache)
Nonsense mutations, responsible for ~11% of gene lesions causing human monogenic diseases, introduce premature termination codons (PTCs) that lead to truncated proteins and nonsense-mediated mRNA decay (NMD). In the central nervous system (CNS), these mutations drive severe, progressive neurological conditions such as spinal muscular atrophy, Rett syndrome, and Duchenne muscular dystrophy. Readthrough therapies—strategies to override PTCs and restore full-length protein expression—have evolved from early aminoglycosides to modern precision tools including suppressor tRNAs, RNA editing, and CRISPR-based platforms. Yet clinical translation remains hampered by inefficient CNS delivery, variable efficacy, and the absence of personalized stratification. In this review, we propose a translational framework—the 4 Ds of Readthrough Therapy—to systematically address these barriers. The framework dissects the pipeline into Detection (precision patient identification and biomarker profiling), Delivery (engineered vectors for CNS targeting), Decoding (context-aware molecular correction), and Durability (long-term safety and efficacy). By integrating advances in machine learning, nanocarriers, base editing, and adaptive trial designs, this roadmap provides a structured strategy to bridge the translational gap. We advocate that a synergistic, modality-tailored approach will transform nonsense suppression from palliative care to durable, precision-based cures for once-untreatable neurological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
ORCID-Profile: Zhenyun Zhu
Förderung
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Zitieren
APA
Li, J., Zhu, Z., & Xu, S. (2026). A Translational Roadmap for Neurological Nonsense Mutation Disorders. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031418
Vancouver
Li J, Zhu Z, Xu S. A Translational Roadmap for Neurological Nonsense Mutation Disorders. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031418
BibTeX
@article{Li2026,
author = {Li, Jiaqing and Zhu, Zhenyun and Xu, Sanqing},
title = {A Translational Roadmap for Neurological Nonsense Mutation Disorders},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27031418}
}
EUVIMED